Laforest L - Search Results

1

Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy.

Laforest L, Moulin P, Souchet T, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Kieffer A, Van Ganse E. Laforest L, et al. Atherosclerosis. 2008 Aug;199(2):368-77. doi: 10.1016/j.atherosclerosis.2007.11.033. Epub 2008 Jan 11. Atherosclerosis. 2008. PMID: 18191135 Clinical Trial.

2

Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.

Laforest L, Souchet T, Moulin P, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Van Ganse E. Laforest L, et al. Arch Cardiovasc Dis. 2009 Jan;102(1):43-50. doi: 10.1016/j.acvd.2008.06.021. Epub 2009 Jan 25. Arch Cardiovasc Dis. 2009. PMID: 19233108 Free article.

3

Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.

Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, Chretin S, Yin D, Alemao E, de Pouvourville G. Van Ganse E, et al. Among authors: laforest l. Atherosclerosis. 2006 Mar;185(1):58-64. doi: 10.1016/j.atherosclerosis.2005.05.036. Epub 2005 Jul 20. Atherosclerosis. 2006. PMID: 16038912 Clinical Trial.

4

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.

Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D. Van Ganse E, et al. Among authors: laforest l. Curr Med Res Opin. 2005 Sep;21(9):1389-99. doi: 10.1185/030079905X59139. Curr Med Res Opin. 2005. PMID: 16197657

5

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Van Ganse E, et al. Among authors: laforest l. Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003. Clin Ther. 2007. PMID: 17919548

6

Asthma patients' self-reported behaviours toward inhaled corticosteroids.

Laforest L, El Hasnaoui A, Pribil C, Ritleng C, Osman LM, Schwalm MS, Le Jeunne P, Van Ganse E. Laforest L, et al. Respir Med. 2009 Sep;103(9):1366-75. doi: 10.1016/j.rmed.2009.03.010. Epub 2009 Apr 24. Respir Med. 2009. PMID: 19398316 Free article.

7

Asthma patients' perception of their ability to influence disease control and management.

Laforest L, El Hasnaoui A, Pribil C, Ritleng C, Schwalm MS, Van Ganse E. Laforest L, et al. Ann Allergy Asthma Immunol. 2009 May;102(5):378-84. doi: 10.1016/S1081-1206(10)60508-X. Ann Allergy Asthma Immunol. 2009. PMID: 19492658

8

Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey.

Laforest L, Van Ganse E, Ritleng C, Desamericq G, Letrilliart L, Moreau A, Rosen S, Mechin H, Chamba G. Laforest L, et al. BMC Public Health. 2009 Sep 15;9:337. doi: 10.1186/1471-2458-9-337. BMC Public Health. 2009. PMID: 19754928 Free PMC article.

9

Correlates of adherence to respiratory drugs in COPD patients.

Laforest L, Denis F, Van Ganse E, Ritleng C, Saussier C, Passante N, Devouassoux G, Chatté G, Freymond N, Pacheco Y. Laforest L, et al. Prim Care Respir J. 2010 Jun;19(2):148-54. doi: 10.4104/pcrj.2010.00004. Prim Care Respir J. 2010. PMID: 20094689 Free PMC article.

10

Mixed dyslipidemias in primary care patients in France.

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E. Laforest L, et al. Vasc Health Risk Manag. 2012;8:247-54. doi: 10.2147/VHRM.S27668. Epub 2012 Apr 19. Vasc Health Risk Manag. 2012. PMID: 22566746 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters